Abstract

LAM S5 is a polysulphated derivative of the glucan laminarian that inhibits basic fibroblast growth factor (bFGF) binding and the bFGF-stimulated proliferation of fetal bovine heart endothelial (FBHE) cells. This report demonstrates that LAM S5 has anti-angiogenic activity, as shown by inhibition of tubule formation by endothelial cells cultured on Matrigel and inhibition of vascularisation of the chick chorioallantoic membrane. In addition, LAM S5 caused a tumour growth delay of the murine RIF-1 tumour of 2.6 days (P = 0.01).

Highlights

  • At least some of the anti-tumour activities of these compounds can be attributed to inhibition of heparin-binding angiogenic growth factors produced by tumour cells (Zugmaier et al, 1992; Nakayama et al, 1993)

  • We have recently identified a highly sulphated derivative of the /3-1,3glucan laminarin, designated LAM S5, which inhibits basic fibroblast growth factor binding and the bFGF-stimulated proliferation of fetal bovine heart endothelial (FBHE) cells (Hoffman et al, 1995a). bFGF is a potent angiogenic factor and is present at elevated levels in the urine of some cancer patients (Nguyen et al, 1994)

  • In this study we have evaluated the anti-angiogenic and anti-tumour activities of LAM S5

Read more

Summary

Inhibition of angiogenesis and murine tumour growth by laminarin sulphate

'Clinical Oncology and Radiotherapeutics Unit, MRC Centre, Hills Road, Cambridge CB2 2QH, UK; 2Department of Pharmacy, University of Regensburg, 93040 Regensburg, Germany. Summary LAM S5 is a polysulphated derivative of the glucan laminarin that inhibits basic fibroblast growth factor (bFGF) binding and the bFGF-stimulated proliferation of fetal bovine heart endothelial (FBHE) cells. Inhibition of tumour neovascularisation, or angiogenesis, is a promising new strategy for the treatment of cancer (see Scott and Harris, 1994 for recent review) Several polysulphated carbohydrates, such as pentosan polysulphate (PPS), chitin derivatives and the bacteria-derived DS-4152, are antiangiogenic and inhibit tumour growth in animal models (Zugmaier et al, 1992; Murata et al, 1991; Tanaka et al, 1989). We have recently identified a highly sulphated derivative of the /3-1,3glucan laminarin, designated LAM S5 (molecular weight 12 kDa), which inhibits basic fibroblast growth factor (bFGF) binding and the bFGF-stimulated proliferation of fetal bovine heart endothelial (FBHE) cells (Hoffman et al, 1995a). In this study we have evaluated the anti-angiogenic and anti-tumour activities of LAM S5

Materials and methods
Tissue culture
Endothelial cell tubule formation
Results and discussion
Agarose control
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.